Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And just like RLFTF, the CEO (Michael Frank) and other fat cat insiders still get their fat salaries and bonus checks. No loss for them. They still did just fine in the pandemic.
As predicted, RVVTF followed the same path as RLFTF. Both foreign tiny biotechs, and the FDA doesn't give them the attention they give USA Big Pharma. I saw this coming, and I feel bad for the longs. I've also never had any faith in this CEO's competency level. He's always been too hooked on shrooms. At least the O/S is not in the stratosphere like it is with RLFTF, so I don't think an R/S is on the horizon just yet. But clearly investor patience has worn thin, COVID is winding down, and the big money has already been made for most with this pandemic. JMHO.
This sucks bad. We all got taken to the woodshed by this CEO three years. Now is going to be 3 years for this to even go above a dime. I had hope with this stock. When I saw ECO pumping the stock. I know it's was all over. God luck CW.
A lot of lawsuit talk on the reddit board. Even Biomedical Trader blamed management this morning as to the reason for this disaster.
If you are right about us being scammed, CEO Michael Frank should go into hiding. Seriously.
I fear the sentiment is as it is over on the Reddit board and MF will drag this out as long as possible to collect his six figure salary.
As was stated over there we were told they would unblind the data regardless whether or not the FDA approved the end points. Now he claims they will not unblind the data.
This has all the markings of a scam at this point. Unfortunately I’ve been a part of these before on the OTC with fraudulent CEO’s milking it to the last drop
Good luck on your increased investment. If I had powder to bet with I believe one half of my brain would have talked me in to buying more on the dip because of A.
As it is I continue to hold and hope that A will be the reason that an entity with way more clout is already planning its move to take Bucillamine to the finish line.
Me too. Broke it down to 2 bets.
A. on the science, with good promise and
B. on the company, a long shot.
I bought today, but not because of B.
A part of me wishes it was well and truly over, even with the massive loss entailed. At least then one could move on with a tried but failed mindset instead of more holding and hoping. Selling would equally suck because of FOMO.
Fress sure did make a smart move back in December '20.
Your not alone CW,all us longs are feeling the pain.Lets hope we can get some back.
I'm disappointed today more than most. I couldn't even follow the stock after the initial selloff. No point in selling here. I just hope to make some money back in time and maybe close the year at a dime. Who knows? Holding but not expecting greatness anymore. I lost a lot today on paper. Like others selling at $.70 would have made too much sense. Ugh.
Yes I had just under 300,000 shares at a average of 20 cents.
No chance. He took investor mon eye at .15
All sounds good uncle Mike. You have ba$$s. I will hold and ride your coattails.
Thanks again for you insight.
Be interesting to see if the CEO bought the dip today and files a form 4
We will find out on Wednesday.
I have been down $700,000 on paper, on one stock.
You get use to the wild swings after a while on OTC.
Being diversified helps a lot, Never put all the eggs in one basket.
There are no, no risk investments. One of the 10 largest US banks failed this month.
Poof just like, it was dead. Silicone Valley Bank.
Risk reward wise, this is a great one. Today's news does not change my mind, it only reminds me how many wolves and sheep there are gaming the stock market, just like claims made that the FDA games the drug winners and losers, there are games played to milk retail of their shares..
I never sell shares at loss. That is just my style. I also never buy shares in company I am not willing to buy more on dips.
L-2 on $RVVTF was all screwed up this morning and short MMs (convertible MMs even) were all over it, and it was hard to tell what was going on with most OTC stocks this morning. It took over 2 hours for most of the L-2 OTC stock data mess to clear up.
I started buying more RVVTF shares about 30 minutes ago.
There is a huge chart gap overhead formed at the open today, that needs to fill, back up to at least .068 range
No one should have sold the bottom today, that is a rookie mistake.
Bid support seems to be strong at the .037 Fib range now.
The news left a lot of future rally doors open for solid upside. Some body, BP(?) Hedge Funds(?) wanted this stock way down and got it down 70% off the price RVVTF raised 4.3 Million dollars at, namely at .10/share
We can speculate later on what the 2nd half of the PR says that is bullish, lots of bullish options listed.
https://www.proactiveinvestors.com/companies/news/1009552/revive-therapeutics-provides-update-of-phase-3-clinical-study-for-bucillamine-in-treatment-of-covid-19-1009552.html
Be interesting to see if the CEO bought the dip today and files a form 4.
My opinions on RVVTF have not changed. In fact it is a better buy now than before, who would not buy at 70% off the price they just raised 4.3 Million dollars at? or 95% off the 2 year high?
The FDA trial is still underway.
Google dollar cost averaging folks.
I have never owned any shares in this security just seen it going down since last October from .30 to where it is now
You should never dump when news causes a dump. Remember there are lots of holders with millions of shares. Should at least move up from these levels over the next few days with more clarity. Let the dump die out. They have one than one item in the pipeline.. Let the price recoup let your emotions subside before jumping out. Calm down and wait for a better price before selling. That’s my opinion.
Your down 51,000.00 dollars?
Cannacord is probably in the process of renting a bunch of nooses right now.
Yep. So said for all who took the pump
Imagine those investors who bought the offering at a premium
govprs, BTW unfortunately your .05 prediction was wrong! LOL
Dont know if it will help but BMT on reddit said he is down 117,000......misery loves company.
wise man, there is still a lot of value in this stock once all the dust settles from this disappointment.
Hotel Delta.....Im going to hold as I need .20 to break even, down 51,000 right now.
Rubberneck2 I feel your pain, this is money that I had no business throwing away especially on a penny stock. I never learn my lesson but now that I am such deep shit with money issues, I am done with investing. These days it's all short sellers and day traders who profit. Long term investors are getting screwed big time. Since the company is still afloat, maybe just maybe something good will happen for us. At this point it doesn't pay to sell. I'll just wait it out until the end of the year. GLTU and all who thought this shitty little company would make us some serious money.
Rubber.....yep,I was up nice when this shot up before could of sold but was
greedy (as usual) and blew it......I did the same with another little sub penny
stock I bought about the same time as RVVTF.....bought in at 0.0004 it ran to 4 cents
and I was up 15,000 on a 250 investment..did I sell....NOOOOO and now its back
down to 0.0003.....this stuff isnt for me,I will hold and see what happens,hope it
maybe get back to .15 - .20 and I can break even at some point.
Well said. Penny stocks are always a risk as all of you know. Ups and downs are normal. I'm still hanging on, won't sell, no reason too I don't need the loss until the end of the year. I still have hope I can at least recover my loss by the end of the year.
Noble words in the face of a shitty result It's only. Within 7 months this stock put me in a position to pay off my mortgage and all other debt too. Greed prevented me from doing so. And here we are, with no one to blame but ourselves.
Lessons learned.
Sooooo. No MF monogrammed sweatpants now?
HAHAHAHAHAHAHA!!!!!
I have no one to blame but myself,really thought they had something and as I said
im ride or die.....well im dead.
Don’t worry ric said he was buying all shares under a nickel
Lost a shit ton of money on this crap. I shoulda, coulda woulda sold a long time ago. I think I am done with the stock market for good. It's never a good time to lose money especially now!! So upset and angry.
just sold. not even joking. left a few "just-in-case". i afforded myself more than i could lose to risk. not having fun
So thats it......probalby with the dump thats coming will just stay and see if I can at least break even in a few years
unless they go bankrupt.....thats enough of stocks for me,not my thing.
......"the Study was not designed to take into account all of the symptom assessments and supporting data outlined in the FDA guidelines to warrant a primary symptom-based endpoint for COVID-19 studies".
As a layman. I read that as "even though guilines were in place, we ignored them and did our own thing."
Am I wrong?
Well, can't sell, too much invested in this stock. I'll have to wait it out and if this continues I'll sell later in the year and take the loss and mend my wounds.
They are clueless. They don’t know what is in the stockholders best interest
I expect lawsuits
Seriously what is the idea now we all gonna cut our loss? File a lawsuit? Wait it out for MF to save the day last minute?
So unfortunately (or maybe fortunately) our trial did not take into account how many boogers would be left in patients nose after the 2 weeks is up
Followers
|
337
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36642
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |